CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy, and Tomocube, a leader in holotomography (HT) technology, today announced a ...
In a breakthrough for research fields as diverse as diabetes, atherosclerosis and biofuels, the mass, concentration, volume, and surface area of individual lipid droplets have been measured in live, ...
Tomocube (Co-CEOs Yonggeun Park and Kihyun Hong), a specialized company in three-dimensional label-free cell imaging, announced on the 25th that it has finalized its public offering price at 16,000 ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
TomoCube, a South Korea-based developer of optical and microscopy platforms for bioimaging, expects its latest holotomography system to prove the value of the technique in a number of applications.
Tomocube is experiencing a sharp decline compared to its IPO price on the first day of listing on the KOSDAQ market. As of 10:29 AM on the 7th, Tomocube is trading at 11,700 KRW, down 26.88% from its ...
The Korea Herald is publishing a series of articles highlighting South Korea’s promising start-ups in the emerging sectors of digital health care and next-generation medical devices. This is the third ...
Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
-- First commercially available spinning-disk confocal holotomographic instrument, enabling advanced 3D imaging with fluorescence-based detection -- New system showcased at SPAOM24 (20th-22nd November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results